Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHCPR CONSIDERING FORMATION OF TECHNOLOGY ASSESSMENT CONSORTIUM

This article was originally published in The Gray Sheet

Executive Summary

AHCPR CONSIDERING FORMATION OF TECHNOLOGY ASSESSMENT CONSORTIUM composed of government, industry, academia, and health care provider representatives, Lisa Simpson, MD, a senior policy analyst in the Agency for Health Care Policy and Research, said at a Sept. 20 meeting of the National Association for Medical Equipment Services in Washington, D.C. The agency, according to Simpson, is planning to form a consortium that would "come together to conduct [technology] assessments, make available the results of those assessments, and provide technical assistance to purchasers, providers, and certified payers in judging the value" of adopting new technologies for "modified benefits packages."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002833

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel